Microbot Medical Inc. (NASDAQ:MBOT)
Microbot Medical Inc. is engaged in the research, design, development and commercialization of micro-robotics assisted medical technologies. Its product candidate includes the Self Cleaning Shunt for the treatment of hydrocephalus and Normal Pressure Hydrocephalus and TipCAT, a self-propelling, semi-disposable endoscope which is being developed initially for use in colonoscopy procedures. Microbot Medical Inc., formerly known as Stemcells, Inc., is headquartered in Hingham, MA.
Microbot Medical Inc. (NASDAQ:MBOT)’s Financial Overview
Microbot Medical Inc. (NASDAQ) surged 1.35% yesterday to close its trading session at $4.49. The company has 1 year Price Target of $26.25. Microbot Medical Inc. has 52-Week high of $8.48 and 52-Week Low of $0.52. The stock touched its 52-Week High on 18.75 and 52-Week Low on 4.20. The stock traded with the volume of 38979 shares yesterday. The firm shows the market capitalization of $13.87 Million.
Microbot Medical Inc. (NASDAQ) reported its last quarterly earnings on 6/29/2018 where the firm reported its Actual EPS of $-0.6/share against the analyst consensus estimate of $-0.6/share. The difference between the actual and expected EPS is $0 a share with a surprise factor of 0%.
The firm is trading with SMA20 of -11.74 Percent, SMA50 of -25.43 Percent and SMA200 of -55.73 percent. Microbot Medical Inc. has P/S value of 0 while its P/B value stands at 1.6. Similarly, the company has Return on Assets of -58.7 percent, Return on Equity of -61.9 percent and Return on Investment of 0 Percent. The company shows Gross Margin and Operating Margin of 0 percent and 0 percent respectively.
The Stock currently has Analyst’ mean Recommendation of 1 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.
The 1 analysts offering 12-month price forecasts for Microbot Medical Inc have a median target of 26.25, with a high estimate of 26.25 and a low estimate of 26.25. The median estimate represents a +484.63% increase from the last price of 4.49.
Microbot Medical Inc. is estimated to report earnings on 11/13/2018. The upcoming earnings date is derived from an algorithm based on a company’s historical reporting dates.Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date.
Goldfield Corporation (The) (NYSE:GV)
The Goldfield Corporation is a leading provider of electrical construction and maintenance services in the energy infrastructure industry in the southeastern United States. The company specializes in installing and maintaining electrical transmission lines for a wide range of electric utilities. Goldfield is also involved in the development of high-end condominium projects on Florida’s east coast.
Goldfield Corporation (The) (NYSE:GV)’s Financial Outlook
There is no forecast data available.
Our vendor, Zacks Investment Research, hasn’t provided us with the upcoming earnings report date.
The Stock declined -1.51% and closed its last trading session at $3.26. The company has the market capitalization of $85.97 Million. The stock has 52-week high of $5.35 and 52-Week low of $3.23. The firm touched its 52-Week high on 5.35 and 52-Week low on 3.31. The company has volume of 38776 shares. The company has a total of 26.37 Million shares outstanding.
The company has YTD performance of -33.47 percent. Beta for Goldfield Corporation (The) stands at 1.72 while its ATR (average true range) is 0.15. The company has Weekly Volatility of 4.65%% and Monthly Volatility of 3.73%%.
Goldfield Corporation (The) has distance from 20-day Simple Moving Average (SMA20) of -14.43%, Distance from 50-Day Simple Moving Average of -22.09 percent and Distance from 200-Day Simple Moving Average of -26.12%.
The Company currently has ROA (Return on Assets) of 8.3 percent, Return on Equity (ROE) of 14 Percent and Return on Investment (ROI) of 8.4% with Gross margin of 18.7 percent and Operating & Profit margin of 7.3% and 6.4% respectively.